Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Thuss-Patience

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Oncology Research and Treatment|April 30, 2018
Immune Checkpoint Inhibition in Gastro-Oesophageal CancerElizabeth Smyth, Peter C Thuss-Patience
Future Oncology (London, England)|October 10, 2006
Docetaxel in the treatment of gastric cancerPeter C Thuss-Patience, Albrecht Kretzschmar, Peter Reichardt
Medizinische Klinik (Munich, Germany : 1983)|February 28, 2006
[Recent progress in the treatment of colorectal cancer]Peter C Thuss-Patience, Peter Reichardt, Hanno Riess, et al.
Gynecologic Oncology|December 22, 2005
Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literatureDaniel Pink, Tanja Lindner, Alicia Mrozek, et al.
Anti-Cancer Drugs|September 10, 2003
Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer: a preliminary phase II studyPeter C Thuss-Patience, Gunter von Minckwitz, Albrecht Kretzschmar, et al.
Oncology|April 1, 2015
High Impact of Histopathological Remission for Prognosis after Perioperative Chemotherapy with ECF and ECF-Like Regimens for Gastric and Gastroesophageal AdenocarcinomaDmitry Bichev, Christoph Treese, Moritz von Winterfeld, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer--a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)Peter C Thuss-Patience, Albrecht Kretzschmar, Dmitry Bichev, et al.
Tumori|May 3, 2011
Hepatic arterial infusion chemotherapy for liver metastases from gastric cancer: an analysis in Western patientsAnne Flörcken, Claudia Schaefer, Dmitry Bichev, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II studyPeter C Thuss-Patience, Albrecht Kretzschmar, Michael Repp, et al.
Anticancer Research|July 7, 2021
Minimally Invasive <i>Versus</i> Open Ivor-Lewis Esophagectomy for Esophageal Cancer or Cancer of the Gastroesophageal Junction: Comparison of Postoperative Outcomes and Long-term Survival Using Propensity Score Matching AnalysisSebastian Knitter, Andreas Andreou, Tobias Hofmann, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Oncology Research and Treatment|April 30, 2018
Immune Checkpoint Inhibition in Gastro-Oesophageal CancerElizabeth Smyth, Peter C Thuss-Patience
Future Oncology (London, England)|October 10, 2006
Docetaxel in the treatment of gastric cancerPeter C Thuss-Patience, Albrecht Kretzschmar, Peter Reichardt
Medizinische Klinik (Munich, Germany : 1983)|February 28, 2006
[Recent progress in the treatment of colorectal cancer]Peter C Thuss-Patience, Peter Reichardt, Hanno Riess, et al.
Gynecologic Oncology|December 22, 2005
Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literatureDaniel Pink, Tanja Lindner, Alicia Mrozek, et al.
Anti-Cancer Drugs|September 10, 2003
Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer: a preliminary phase II studyPeter C Thuss-Patience, Gunter von Minckwitz, Albrecht Kretzschmar, et al.
Oncology|April 1, 2015
High Impact of Histopathological Remission for Prognosis after Perioperative Chemotherapy with ECF and ECF-Like Regimens for Gastric and Gastroesophageal AdenocarcinomaDmitry Bichev, Christoph Treese, Moritz von Winterfeld, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer--a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)Peter C Thuss-Patience, Albrecht Kretzschmar, Dmitry Bichev, et al.
Tumori|May 3, 2011
Hepatic arterial infusion chemotherapy for liver metastases from gastric cancer: an analysis in Western patientsAnne Flörcken, Claudia Schaefer, Dmitry Bichev, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II studyPeter C Thuss-Patience, Albrecht Kretzschmar, Michael Repp, et al.
Anticancer Research|July 7, 2021
Minimally Invasive <i>Versus</i> Open Ivor-Lewis Esophagectomy for Esophageal Cancer or Cancer of the Gastroesophageal Junction: Comparison of Postoperative Outcomes and Long-term Survival Using Propensity Score Matching AnalysisSebastian Knitter, Andreas Andreou, Tobias Hofmann, et al.
Pageof 2